Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

Peptide Schedule Research TeamReviewed Apr 7, 20266 Citations

Tesofensine iconTesofensineSmall moleculeNo amino acid sequence. Icon reflects category theme only.

Tesofensine Dosage Calculator

Weight Loss · Phase 3 · Grade C · ~9 days half-life · Oral

Dosing protocol

Tesofensine Dosage

LevelDoseFrequency
Beginner0.25 mgDaily
Moderate0.5 mgDaily
Aggressive1 mgDaily

Cycle: 24 weeks on, 4 weeks off.

No syringe calculation for this route

Oral

Tesofensine has no default water volume for this calculator, so there are no syringe units to calculate here. Dosing runs 0.25 mg to 1 mg per administration, daily.

If your product does arrive as a powder, use the universal reconstitution calculator and enter your own vial size and water volume.

Open Tesofensine details
Side effects, protocols by goal, storage, and the sources behind these dosing numbers.

About Tesofensine

Beginner, moderate, and aggressive dosing amounts with timing. Free to use.

Tesofensine is a triple monoamine reuptake inhibitor that produced 9.2% body weight loss in 24 weeks at 0.5 mg daily. Oral capsule, no injection. Not FDA-approved; Phase 3 complete in Mexico. Heart rate monitoring required during the full treatment course.

Weight ManagementAppetite RegulationFat LossMood Regulation
Oral. Typical beginner frequency: daily.
Store at 15-30°C (59-86°F). Store capsules at room temperature, 15-30°C.

View side effects and safety warnings →

Quick-Start: How to Use Tesofensine

  1. 1Obtain tesofensine capsules from a verified source with lot-specific third-party certificates of analysis. Confirm capsule dose matches the label (0.25 mg or 0.5 mg).
  2. 2Take one 0.25 mg capsule by mouth each morning before 9 AM. With or without food; pharmacokinetics don't change between fed and fasted states.
  3. 3Continue 0.25 mg daily for 2 to 4 weeks. This is the titration window. Assess tolerability by tracking resting heart rate, dry mouth severity, and sleep quality.
Full usage guide →

Tesofensine Dosing Protocol

Clinical TrialPhase 2 trial: tesofensine in adults with obesity (Astrup et al., Lancet 2008)
LevelDoseFrequency
Beginner0.25 mgDaily
Moderate0.5 mgDaily
Aggressive1 mgDaily
Note:

This one is oral, not injectable. No reconstitution math, no bacteriostatic water, no syringes. You're taking a capsule each morning.

Start at 0.25 mg daily for the first 2 to 4 weeks. The half-life is around 9 days, so you won't reach steady state until roughly week 4 or 5. Don't judge whether it's working before then. The active metabolite M1 has a 16-day half-life on top of that. Effects build slowly and linger long after your last dose.

Take it before 9 AM. This is non-negotiable if you value sleep. Even noon dosing causes insomnia for most people.

Monitor your resting heart rate at baseline and weekly for the first month. If it jumps more than 10 bpm or crosses 100 bpm, hold at the current dose and reassess. Don't rapidly stop and restart; the long half-life means plasma levels shift very slowly.

Gray-market sourcing is the current reality. No US compounding pharmacy pathway exists. Lot-specific COAs with HPLC purity data are the only record of what a given batch contains.

Dosing based on Phase 2 trial: tesofensine in adults with obesity (Astrup et al., Lancet 2008): 6 published references.View all sources →

Ask AI about this math

Cross-check your Tesofensine reconstitution math with AI

Tesofensine Cost

Generic / Research
Gray-market research capsules: ~$40–80/month at 0.5 mg/day. 250 mcg research capsules: ~$80 to ~$186/month at 0.5 mg/day (2 caps/day), depending on the product. Not GMP-certified or pharmaceutical grade.
Compounded
Not on the 503A bulks list and in none of FDA's 503A or 503B nomination categories (October 2026).

Pricing updated 2026-04-09

Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →

Tesofensine Pharmacokinetics

Pharmacokinetics: Active Dose Over Time

t½ = ~9 days (220 hours)
50%25%12.5%100%75%50%25%0%09d18d27d36d45dTime after injectionDose remaining
After 1 half-life (9d): 50% remainsAfter 2 half-lives (18d): 25% remainsAfter 3 half-lives (27d): 12.5% remains
At a 0.5 mg dose: 50% = 0.25 mg remaining after 9d. Moderate-tier frequency in our sources: Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.

Read the full Tesofensine guide →

Related Tools

Frequently Asked Questions

Store Tesofensine at 15-30°C (59-86°F). Store capsules at room temperature, 15-30°C.

The 1.0 mg dose had significantly higher adverse events in the Lancet 2008 Phase 2 trial: more cardiovascular effects (heart rate, blood pressure) and more dropouts. Saniona and Medix decided 0.5 mg hit the best efficacy-to-tolerability ratio for Phase 3. Animal studies showed a beta-blocker could mitigate the cardiovascular signal while preserving appetite suppression, which became a separate program.